-
1.Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade 失效
标题翻译: 用于选择性抑制凝血级联的取代的多环芳基和杂芳基吡嗪酮公开(公告)号:US06908919B2
公开(公告)日:2005-06-21
申请号:US10195573
申请日:2002-07-15
申请人: Michael S. South , Brenda L. Case , Thomas A. Dice , Ricky L. Fenton , Gary W. Franklin , Michael J. Hayes , Horng-Chih Huang , Wei Huang , Darin E. Jones , Carrie L. Kusturin , Richard J. Lindmark , Scott A. Long , William L. Neumann , David B. Reitz , John I. Trujillo , Ching-Cheng Wang , Rhonda Wood , Qingping Zeng , Matthew W. Mahoney , John J. Parlow , Melvin L. Rueppel
发明人: Michael S. South , Brenda L. Case , Thomas A. Dice , Ricky L. Fenton , Gary W. Franklin , Michael J. Hayes , Horng-Chih Huang , Wei Huang , Darin E. Jones , Carrie L. Kusturin , Richard J. Lindmark , Scott A. Long , William L. Neumann , David B. Reitz , John I. Trujillo , Ching-Cheng Wang , Rhonda Wood , Qingping Zeng , Matthew W. Mahoney , John J. Parlow , Melvin L. Rueppel
IPC分类号: A61K38/00 , C07D241/20 , C07D401/12 , C07D403/12 , C07D405/04 , C07D409/04 , C07D409/12 , C07D413/12 , C07D417/12 , C07K5/06 , C07K5/078 , A61K31/495 , A61P7/02
CPC分类号: C07D401/12 , A61K38/00 , C04B35/632 , C07D241/20 , C07D403/12 , C07D405/04 , C07D409/04 , C07D409/12 , C07D413/12 , C07D417/12 , C07K5/06139 , C07K5/06191
摘要: The invention relates to substituted polycyclic aryl and heteroaryl pyrazinone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.
摘要翻译: 本发明涉及可用作凝血级联丝氨酸蛋白酶抑制剂的取代的多环芳基和杂芳基吡嗪酮化合物,以及用于治疗和预防各种血栓形成病症(包括冠状动脉和脑血管疾病)的抗凝血治疗的化合物,组合物和方法。
-
2.Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade 失效
标题翻译: 用于选择性抑制凝血级联的取代的多环芳基和异齿酰基吡嗪酮公开(公告)号:US07119094B1
公开(公告)日:2006-10-10
申请号:US10276174
申请日:2000-11-20
申请人: Michael S. South , John J. Parlow , Darin E. Jones , Brenda Case , Tom Dice , Richard Lindmark , Michael J. Hayes , Melvin L. Rueppel , Rick Fenton , Gary W. Franklin , Horng-Chih Huang , Wei Huang , Carrie Kusturin , Scott A. Long , William L. Neumann , David B. Reitz , John I. Trujillo , Ching-Cheng Wang , Rhonda Wood , Qingping Zeng , Matthew W. Mahoney
发明人: Michael S. South , John J. Parlow , Darin E. Jones , Brenda Case , Tom Dice , Richard Lindmark , Michael J. Hayes , Melvin L. Rueppel , Rick Fenton , Gary W. Franklin , Horng-Chih Huang , Wei Huang , Carrie Kusturin , Scott A. Long , William L. Neumann , David B. Reitz , John I. Trujillo , Ching-Cheng Wang , Rhonda Wood , Qingping Zeng , Matthew W. Mahoney
IPC分类号: A61K31/4965 , C07D241/02
CPC分类号: C07D417/12
摘要: The invention relates to substituted polycyclic aryl and heteroaryl pyrazinone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.
摘要翻译: 本发明涉及可用作凝血级联丝氨酸蛋白酶抑制剂的取代的多环芳基和杂芳基吡嗪酮化合物,以及用于治疗和预防各种血栓形成病症(包括冠状动脉和脑血管疾病)的抗凝血治疗的化合物,组合物和方法。
-
3.Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade 失效
标题翻译: 用于选择性抑制凝血级联的取代的多环芳基和杂芳基吡嗪酮公开(公告)号:US06664255B1
公开(公告)日:2003-12-16
申请号:US09574752
申请日:2000-05-18
申请人: Michael South , John J. Parlow , Darin E. Jones , Brenda Case , Tom Dice , Richard Lindmark , Michael J. Hayes , Melvin L. Rueppel , Horng-Chih Huang , Wei Huang , Scott A. Long , Matthew Mahoney , William L. Neumann , David Reitz , John I. Trujillo , Ching-Cheng Wang , Rhonda Wood , Qingping Zeng , Rick Fenton , Gary W. Franklin , Carrie Kusturin
发明人: Michael South , John J. Parlow , Darin E. Jones , Brenda Case , Tom Dice , Richard Lindmark , Michael J. Hayes , Melvin L. Rueppel , Horng-Chih Huang , Wei Huang , Scott A. Long , Matthew Mahoney , William L. Neumann , David Reitz , John I. Trujillo , Ching-Cheng Wang , Rhonda Wood , Qingping Zeng , Rick Fenton , Gary W. Franklin , Carrie Kusturin
IPC分类号: C07D24120
CPC分类号: C07D417/12 , A61K38/00 , C07D241/20 , C07D401/12 , C07D403/12 , C07D405/04 , C07D409/04 , C07D409/12 , C07D413/12 , C07K5/06139 , C07K5/06191
摘要: The invention relates to substituted polycyclic aryl and heteroaryl pyrazinone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.
摘要翻译: 本发明涉及可用作凝血级联丝氨酸蛋白酶抑制剂的取代的多环芳基和杂芳基吡嗪酮化合物,以及用于治疗和预防各种血栓形成病症(包括冠状动脉和脑血管疾病)的抗凝血治疗的化合物,组合物和方法。
-
4.
公开(公告)号:US20050043313A1
公开(公告)日:2005-02-24
申请号:US10940693
申请日:2004-09-14
申请人: Michael South , Brenda Case , Thomas Dice , Ricky Fenton , Gary Franklin , Michael Hayes , Horng-Chih Huang , Wei Huang , Darin Jones , Carrie Kusturin , Richard Lindmark , Scott Long , William Neumann , David Reitz , John Trujillo , Ching-Cheng Wang , Rhonda Wood , Qingping Zeng , Matthew Mahoney , John Parlow , Melvin Rueppel
发明人: Michael South , Brenda Case , Thomas Dice , Ricky Fenton , Gary Franklin , Michael Hayes , Horng-Chih Huang , Wei Huang , Darin Jones , Carrie Kusturin , Richard Lindmark , Scott Long , William Neumann , David Reitz , John Trujillo , Ching-Cheng Wang , Rhonda Wood , Qingping Zeng , Matthew Mahoney , John Parlow , Melvin Rueppel
IPC分类号: A61K38/00 , C07D241/20 , C07D401/12 , C07D403/12 , C07D405/04 , C07D409/04 , C07D409/12 , C07D413/12 , C07D417/12 , C07K5/06 , C07K5/078 , A61K31/4965 , A61K31/497 , C07D43/02
CPC分类号: C07D401/12 , A61K38/00 , C04B35/632 , C07D241/20 , C07D403/12 , C07D405/04 , C07D409/04 , C07D409/12 , C07D413/12 , C07D417/12 , C07K5/06139 , C07K5/06191
摘要: The invention relates to substituted polycyclic aryl and heteroaryl pyrazinone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.
-
-
-